nDatalyze Corp. (NDATF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $6.08M is the value of all shares combined. Beta 0.10: the stock has moved about 90% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswernDatalyze Corp. (NDATF) trades at $0.08. nDatalyze Corp. is a Canadian technology company developing an AI-powered mental wellness application and licensing databases within the health sector. Market cap: $6.08M, Sector: Healthcare.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for NDATF: NDATF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
nDatalyze Corp. (NDATF) Healthcare & Pipeline Overview
nDatalyze Corp. is a Calgary-based technology firm specializing in an AI-driven mental wellness application and database licensing for the health sector. Concurrently, it manufactures CO2 and alcohol-based essential oil extraction equipment primarily for medical cannabis cultivators, establishing a diversified market presence in health-tech and specialized industrial machinery.
What Is the Investment Thesis for NDATF?
nDatalyze Corp. presents an investment thesis centered on its dual-pronged approach to market penetration: an AI-driven mental wellness application and specialized essential oil extraction equipment. The company's development of an AI platform for mental wellness positions it in a high-growth sector, with increasing demand for digital health solutions. Successful deployment and adoption of this application could unlock significant recurring revenue streams through subscriptions or licensing. Concurrently, its established manufacturing of extraction equipment for medical cannabis cultivators provides exposure to a niche but expanding industrial market. Value drivers include potential intellectual property surrounding its AI algorithms and databases, and the specialized nature of its extraction technology. Key growth catalysts involve the commercial launch and user acquisition for the mental wellness app, securing new database licensing agreements, and expanding the distribution network for its extraction equipment. However, as an OTC Other listed company with a single employee, NDATF faces substantial risks related to liquidity, regulatory oversight, and the ability to scale operations and compete effectively in capital-intensive markets.
Based on FMP financials and quantitative analysis
NDATF Key Highlights
Market Capitalization of $6.08M, indicating a micro-cap company with limited public market valuation.
- Beta of 0.10, suggesting very low volatility relative to the broader market, though this can be influenced by low trading volume on OTC markets.
- Operates with 1 employee, highlighting a highly lean operational structure and potential reliance on external contractors or automation.
- No dividend yield, consistent with a growth-oriented company in early stages of development or with limited profitability.
- Headquartered in Calgary, Canada, positioning it within a developed economy with potential access to skilled labor and capital markets.
What Are NDATF's Key Strengths?
Diversified business model combining AI health-tech with specialized industrial equipment manufacturing.
- Focus on the growing AI-powered mental wellness market and medical cannabis extraction sector.
- Proprietary AI technology and database assets in development.
- Specialized expertise in CO2 and alcohol-based essential oil extraction methods.
- Agile operational structure with a lean team.
What Are NDATF's Weaknesses?
Trades on OTC Other tier, implying lower liquidity and less stringent regulatory oversight.
- Disclosure status is 'Unknown', limiting investor access to comprehensive financial information.
- Operates with only one employee, potentially indicating limited capacity for large-scale operations or rapid expansion.
- Lack of publicly available detailed financial metrics beyond market cap and beta.
- High reliance on successful development and market adoption of its AI application.
What Could Drive NDATF Stock Higher?
NDATF catalyst: Successful commercial launch and initial user adoption of the AI-powered mental wellness application, potentially driving subscription revenues.
- Securing significant new database licensing agreements with healthcare providers or research institutions.
- Expansion of the distribution network or securing large orders for its essential oil extraction equipment, particularly in new medical cannabis markets.
- Continued technological advancements and feature enhancements for the AI mental wellness platform, improving user engagement and market competitiveness.
- Strategic partnerships or collaborations that provide access to new markets, capital, or expertise for either the health-tech or equipment segments.
What Are the Key Risks for NDATF?
Negative return on equity (-49.8%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- High competition in both the AI health-tech and specialized industrial equipment markets, potentially limiting market share and pricing power.
- Significant operational risks due to a lean team of one employee, which could hinder scalability, product development, and customer support.
- Regulatory and compliance risks, particularly concerning the medical cannabis industry, which is subject to evolving legal frameworks.
- Challenges in securing sufficient funding for continued AI development, market penetration, and operational expansion, especially as an OTC Other company.
- The 'Unknown' disclosure status and OTC Other listing inherently carry risks of limited liquidity, price volatility, and difficulty in obtaining reliable financial information.
What Are the Growth Opportunities for NDATF?
- Growth opportunity 1: Expansion of its AI-powered mental wellness application into new markets. The global digital mental health market is projected to reach over $17 billion by 2027, driven by increased awareness, reduced stigma, and technological advancements. nDatalyze can capitalize on this by enhancing its application's features, securing partnerships with healthcare providers or employers, and targeting specific demographic segments. A successful commercial launch and user acquisition strategy for its mental wellness app could significantly increase its user base and generate recurring subscription or licensing revenues, establishing a stronger foothold in the health-tech sector over the next 3-5 years.
- Growth opportunity 2: Broadening the scope and reach of its database licensing operations. The demand for specialized data analytics and insights across various industries, including healthcare, remains robust. nDatalyze can identify new sectors or specific business needs where its existing databases or future data collection capabilities can provide valuable intelligence. By actively marketing its data assets and forming strategic alliances with research institutions, pharmaceutical companies, or other data-driven enterprises, the company could unlock new revenue streams. This expansion could involve tailoring data packages for specific client requirements, potentially leading to multi-year licensing agreements within the next 2-4 years.
- Growth opportunity 3: Capitalizing on the expanding medical cannabis essential oil extraction market. The global medical cannabis market is experiencing significant growth, with projections indicating a market size exceeding $50 billion by 2028. As more regions legalize medical cannabis, the demand for efficient and safe extraction equipment, such as nDatalyze's CO2 and alcohol-based systems, will likely increase. The company can focus on enhancing its equipment's efficiency, scalability, and compliance with evolving regulatory standards. Expanding its sales and distribution network to newly legalized or growing medical cannabis markets could drive substantial equipment sales and service contracts over the next 3-5 years.
- Growth opportunity 4: Strategic partnerships and collaborations for technology integration. Given its focus on AI and data, nDatalyze could pursue partnerships with larger technology firms, healthcare systems, or research organizations. These collaborations could accelerate the development and market penetration of its mental wellness application by integrating it into existing platforms or leveraging broader distribution channels. For instance, partnering with a telehealth provider could embed its AI tool directly into virtual care services, reaching a wider audience. Such strategic alliances could provide access to capital, expertise, and market access, potentially shortening time-to-market for new features or products within 2-3 years.
- Growth opportunity 5: Diversification of its essential oil extraction equipment beyond medical cannabis. While currently focused on medical cannabis, the underlying technology for CO2 and alcohol-based extraction is applicable to a wider range of botanicals and industrial processes. Exploring new markets such as food and beverage flavorings, natural supplement manufacturing, or cosmetic ingredient extraction could open up significant new revenue avenues. This diversification would leverage existing manufacturing capabilities and expertise, reducing reliance on a single industry segment and expanding its total addressable market. Market research into these adjacent sectors could identify viable expansion opportunities within the next 4-6 years.
What Threats Does NDATF Face?
- Intense competition in both the AI health-tech and industrial equipment manufacturing sectors.
- Regulatory changes and compliance challenges, particularly in the medical cannabis industry.
- Challenges in scaling technology and securing significant market share against larger, more established players.
- Risks associated with OTC Other listing, including price volatility and difficulty in raising capital.
- Rapid technological advancements could render current solutions obsolete without continuous innovation.
What Are NDATF's Competitive Advantages?
- Proprietary AI technology: Development of a specialized AI-powered application for mental wellness could create a unique offering.
- Specialized database assets: Licensing unique or niche databases provides a distinct data-driven advantage.
- Dual business model: Diversification across health-tech and specialized industrial equipment reduces reliance on a single market.
- Niche market expertise: Manufacturing specific essential oil extraction equipment caters to a specialized and growing industry segment.
- Technological expertise in extraction: Proficiency in both CO2 and alcohol-based extraction methods offers versatility to clients.
What Does NDATF Do?
nDatalyze Corp., founded in 2018 and headquartered in Calgary, Canada, operates at the intersection of healthcare technology and specialized industrial equipment manufacturing. The company initially began as MedXtractor Corp. before rebranding to nDatalyze Corp. in October 2021, signaling a strategic shift towards data-driven solutions. Its core health-tech endeavor involves the active development of an artificial intelligence-powered online application specifically designed to support individual mental wellness. This application aims to leverage AI to provide insights and potentially predictive analysis related to consumer behavior within the mental health domain. Complementing its AI initiatives, nDatalyze also engages in the licensing of its proprietary databases, further solidifying its presence in the data analytics sector. Beyond its digital health pursuits, the company maintains a distinct manufacturing segment. It produces and distributes specialized equipment for essential oil extraction, utilizing both CO2 and alcohol-based methodologies. This machinery is primarily targeted at medical cannabis cultivators, addressing a specific industrial need within the burgeoning cannabis sector. This dual operational focus allows nDatalyze Corp. to tap into diverse market segments, from the rapidly expanding digital health and AI analytics space to the specialized equipment demands of the medical cannabis industry. With its headquarters in Canada, the company positions itself to serve both domestic and potentially international markets with its technology and manufacturing capabilities.
What Products and Services Does NDATF Offer?
- Develops an artificial intelligence-powered online application for individual mental wellness.
- Engages in licensing its proprietary databases, primarily within the health sector.
- Manufactures specialized equipment for essential oil extraction using CO2 methods.
- Manufactures specialized equipment for essential oil extraction using alcohol-based methods.
- Distributes essential oil extraction machinery primarily to medical cannabis cultivators.
- Focuses on technology-driven solutions within the broader health sector.
- Leverages AI for insights and predictive analysis in consumer behavior.
- Offers solutions that cater to both digital health and industrial equipment needs.
How Does NDATF Make Money?
- Generates revenue through the development and potential future licensing or subscription models for its AI mental wellness application.
- Earns income from licensing its proprietary databases to various entities, likely on a recurring or project-specific basis.
- Sells specialized CO2 and alcohol-based essential oil extraction equipment to medical cannabis cultivators.
- Potentially offers maintenance, support, or consumables related to its extraction equipment, though not explicitly stated.
- Operates with a diversified revenue strategy spanning health-tech software/data and industrial hardware sales.
What Industry Does NDATF Operate In?
nDatalyze Corp. operates within two distinct yet interconnected industry contexts: healthcare information services, particularly AI-driven health solutions, and specialized equipment manufacturing for the medical cannabis sector. The healthcare information services market is experiencing significant growth, driven by increasing adoption of digital health technologies, demand for personalized wellness solutions, and the integration of AI for predictive analytics. nDatalyze's AI mental wellness application positions it within this expanding landscape, aiming to capture a share of the digital mental health market, which is projected to grow substantially over the next decade. The competitive landscape includes established tech giants and numerous startups vying for innovation in AI and health. Simultaneously, the company's essential oil extraction equipment business caters to the medical cannabis industry, a sector undergoing rapid expansion and regulatory evolution globally. This niche market requires specialized, high-precision machinery for efficient and compliant production, where nDatalyze competes with other industrial equipment manufacturers. Its dual focus allows it to diversify revenue streams but also requires navigating distinct market dynamics and competitive pressures.
Who Are NDATF's Key Customers?
- Individuals seeking support and insights for their mental wellness through the AI-powered application.
- Businesses and organizations interested in licensing specialized databases for data analytics and insights.
- Medical cannabis cultivators requiring advanced equipment for essential oil extraction.
- Potential future customers in other botanical extraction industries if diversification occurs.
- Research institutions or healthcare providers who might license data or integrate the mental wellness app.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
Financial Health
nDatalyze Corp.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
NDATF Valuation & Market Position
With a $6.08M market cap, nDatalyze Corp. sits in the micro-cap segment of the market.
Key Financial Metrics
Return on equity for nDatalyze Corp. stands at -49.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -61.9%, showing how much profit it generates from its asset base. Its free cash flow yield is -0.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 18.85 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -7.3%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
nDatalyze Corp. operates in the Healthcare sector. It is headquartered in Calgary, Canada.
NDATF Financials
Bull Case vs Bear Case
Bull Case
- Diversified business model combining AI health-tech with specialized industrial equipment manufacturing.
- Focus on the growing AI-powered mental wellness market and medical cannabis extraction sector.
- Proprietary AI technology and database assets in development.
- Specialized expertise in CO2 and alcohol-based essential oil extraction methods.
Bear Case
- Trades on OTC Other tier, implying lower liquidity and less stringent regulatory oversight.
- Disclosure status is 'Unknown', limiting investor access to comprehensive financial information.
- Operates with only one employee, potentially indicating limited capacity for large-scale operations or rapid expansion.
- Lack of publicly available detailed financial metrics beyond market cap and beta.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
NDATF Latest News
No recent news available for NDATF.
NDATF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for NDATF.
Price Targets
Wall Street price target analysis for NDATF.
NDATF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for NDATF; grades run from A+ (80-100) to F (below 30).
Leadership: James Morris Durward
Chief Executive Officer
James Morris Durward serves as the Chief Executive Officer of nDatalyze Corp., leading the company's strategic direction and operational execution. While specific details regarding his prior career history and educational background are not publicly provided, his role as the managing individual for the company's operations suggests a foundational involvement in its establishment and evolution. He is responsible for steering nDatalyze Corp.'s dual business focus, encompassing both its innovative health-tech initiatives and its specialized manufacturing segment. His leadership is critical in navigating the competitive landscapes of AI-driven solutions and industrial equipment.
Track Record: Under James Morris Durward's leadership, nDatalyze Corp. has undergone significant transformation, including its strategic name change from MedXtractor Corp. to nDatalyze Corp. in October 2021. This rebranding marked a pivotal shift towards a greater emphasis on data analytics and artificial intelligence within the health sector. He has overseen the active development of the company's AI-powered online application for mental wellness and the continued engagement in licensing its databases. Concurrently, he has maintained the manufacturing and distribution of specialized essential oil extraction equipment, demonstrating a commitment to diversifying the company's revenue streams and market reach.
NDATF OTC Market Information
nDatalyze Corp. trades on the OTC Other tier, which represents the lowest tier of the OTC market. Unlike companies listed on major exchanges like the NYSE or NASDAQ, which have stringent listing requirements regarding financial health, market capitalization, and corporate governance, OTC Other companies face minimal to no reporting standards. This tier typically includes companies that are not required to or choose not to file financial reports with the SEC, or those that are in financial distress. Consequently, investors often have limited access to current and comprehensive financial information, making due diligence more challenging and increasing investment risk compared to higher-tier OTC markets or national exchanges.
- OTC Tier: OTC Other
- Limited Information: The 'Unknown' disclosure status means investors lack access to critical financial and operational data, making informed decision-making exceptionally difficult.
- Low Liquidity: Extremely low trading volume can lead to wide bid-ask spreads and difficulty in buying or selling shares without affecting the price.
- Price Volatility: Shares can be subject to extreme price fluctuations due to low trading volume and limited public information, making them highly speculative.
- Regulatory Oversight: OTC Other companies are subject to significantly less regulatory scrutiny compared to major exchanges, increasing the potential for fraud or mismanagement.
- Difficulty in Raising Capital: The lack of transparency and liquidity can make it challenging for the company to attract institutional investors or raise capital for growth initiatives.
- Verify any available financial statements or reports, even if not SEC-filed, for consistency and accuracy.
- Research management's background and track record beyond what is publicly stated, if possible.
- Investigate the actual operational status and market traction of its AI application and extraction equipment.
- Assess the competitive landscape and nDatalyze's differentiation within its specific niches.
- Understand the company's capital structure and any potential dilution from future fundraising efforts.
- Evaluate the company's legal and regulatory compliance, especially concerning its medical cannabis equipment business.
- Consider the long-term viability of the business model given the limited employee count and 'Unknown' disclosure.
- Established Founding Year: Founded in 2018, indicating several years of operation and development.
- Headquarters in Calgary, Canada: A developed economy with established business infrastructure.
- Specific Product Development: Active development of an AI-powered mental wellness application and database licensing.
- Tangible Manufacturing Segment: Production and distribution of specialized essential oil extraction equipment.
- Strategic Name Change: Rebranding from MedXtractor Corp. to nDatalyze Corp. in 2021 suggests a deliberate evolution of business focus.
nDatalyze Corp. Healthcare Stock: Key Questions Answered
Is NDATF a good stock to buy?
Stock Expert AI does not rate NDATF buy, sell or hold. nDatalyze Corp. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the NDATF stock price today?
The last price recorded on this page for nDatalyze Corp. (NDATF) is $0.08, as of the Nov 19, 2026 trading session. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What are the primary revenue streams for nDatalyze Corp.?
nDatalyze Corp. generates revenue through distinct, yet complementary, channels. One primary stream is anticipated from its AI-powered online application for mental wellness, which could involve subscription fees, licensing agreements, or usage-based charges upon its commercial launch.
What are the key factors to evaluate for NDATF?
Evaluate NDATF on fundamentals, analyst consensus, and risk factors. Beta of 0.10, suggesting very low volatility relative to the broader market, though this can be influenced by low trading volume on OTC markets. Not financial advice.
How frequently does NDATF data refresh on this page?
NDATF's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven NDATF's recent stock price performance?
nDatalyze Corp. (NDATF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified business model combining AI health-tech with specialized industrial equipment manufacturing. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NDATF overvalued or undervalued right now?
nDatalyze Corp. (NDATF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research NDATF before investing?
Before investing in nDatalyze Corp. (NDATF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Data provided for informational purposes only.
- Limited financial data beyond market cap and beta was available, impacting the depth of financial analysis.